MiRNA Sequencing and Assay Market worth 343 million by 2024

By -

The miRNA sequencing and assay market is projected to reach USD 343 million by 2024 from USD 182 million in 2018, at a CAGR of 11.2%. Growth in this market is driven by factors such as the advantages of miRNA sequencing over other technologies, increasing

(EMAILWIRE.COM, March 15, 2019 ) Sequencing consumables are projected to hold the largest share of the miRNA sequencing and assay market during the forecast period.

Based on product, the miRNA sequencing and assays market is segmented into library preparation kits and sequencing consumables. Sequencing consumables dominated the market with a larger share in 2018. The large share of this segment can primarily be attributed to the growing demand for consumables and increasing adoption of small RNA sequencing.

The research and academic institutes end-user segment held the largest share of the market in 2018

Based on end users, the miRNA sequencing & assays market is segmented into academic and research institutes and contract research organizations. In 2018, academic and research institutes accounted for the largest share of the miRNA sequencing & assays market. The large share of this segment can be attributed to the availability of research grants and the increasing focus of market players on providing efficient miRNA sequencing products and services for research applications.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=109895336

North America dominated the miRNA sequencing and assay market in 2018

North America is estimated to account for the largest share of the market in 2018. Factors such as increasing investments in the development of sequencing, growing research in the fields of genomics and RNA biology, and the rising demand for economical, high-throughput techniques for miRNA analysis are driving the growth of the miRNA sequencing & assays market in this region.

Major vendors in the Microscope software market include Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Germany), Takara Bio (Japan), and NEB (UK), among others.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=109895336

Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more